Home > Qtrly Results > ONESOURCE SPECIALTY PHARMA

ONESOURCE SPECIALTY PHARMA
Quarterly Results Analysis [Sep2026]

ONESOURCE SPECIALTY PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ONESOURCE SPECIALTY PHARMA
Please provide your vote to see the results

ONESOURCE SPECIALTY PHARMA Quarterly Results

Consolidated Sep2026
UnAudited
Jun2026
UnAudited
Mar2026
UnAudited
Dec2025
UnAudited
Sep2025
UnAudited
Jun2025
UnAudited
Mar2025
UnAudited
Dec2024
UnAudited
Revenues ₹516 Cr ₹449 Cr ₹428 Cr ₹290 Cr ₹376 Cr ₹327 Cr ₹426 Cr ₹393 Cr
Expenses ₹353 Cr ₹326 Cr ₹336 Cr ₹273 Cr ₹269 Cr ₹239 Cr ₹243 Cr ₹251 Cr
Operating Income ₹163 Cr ₹123 Cr ₹92 Cr ₹17 Cr ₹106 Cr ₹88 Cr ₹183 Cr ₹142 Cr
Other Income ₹1 Cr ₹4 Cr ₹2 Cr ₹5 Cr ₹3 Cr ₹5 Cr ₹3 Cr ₹7 Cr
Interest ₹35 Cr ₹31 Cr ₹23 Cr ₹38 Cr ₹34 Cr ₹27 Cr ₹33 Cr ₹46 Cr
Depreciation ₹75 Cr ₹72 Cr ₹72 Cr ₹70 Cr ₹70 Cr ₹68 Cr ₹68 Cr ₹69 Cr
Profit Before Tax ₹53 Cr ₹20 Cr ₹0 Cr ₹-93 Cr ₹6 Cr ₹-4 Cr ₹84 Cr ₹-67 Cr
Profit After Tax ₹57 Cr ₹25 Cr ₹5 Cr ₹-89 Cr ₹10 Cr ₹0 Cr ₹99 Cr ₹-69 Cr
EPS ₹5.01 ₹2.18 ₹0.40 ₹-7.74 ₹0.92 ₹-0.02 ₹8.61 ₹-6.02
Industry Peers & Returns1W1M1Y
ONESOURCE SPECIALTY PHARMA 12% -1.3% -14.4%
SUN PHARMACEUTICAL INDUSTRIES 2% -4.4% 3.7%
DIVIS LABORATORIES 7.1% 2.5% 46.6%
TORRENT PHARMACEUTICALS 1.4% -5.7% 27.6%
CIPLA 2% -0.2% -14.3%
DR REDDYS LABORATORIES 3.6% 8% 4.2%
MANKIND PHARMA 8.1% -2.2% 1.2%
LUPIN 3% -2.5% 3.5%
ZYDUS LIFESCIENCES 7.4% 4.1% 17.9%

ONESOURCE SPECIALTY PHARMA Quarterly Revenues

Revenues
Q-o-Q

14.97 %

Y-o-Y

37.39 %

Quarters Revenues % Change
Sep2026 ₹516 Cr
14.97
Jun2026 ₹449 Cr
4.86
Mar2026 ₹428 Cr
47.49
Dec2025 ₹290 Cr
-22.73
Sep2025 ₹376 Cr
14.82
Jun2025 ₹327 Cr
-23.17
Mar2025 ₹426 Cr
8.51
Dec2024 ₹393 Cr -

ONESOURCE SPECIALTY PHARMA Quarterly Operating Profit

Operating Profit
Q-o-Q

32.38 %

Y-o-Y

53.33 %

Quarters Operating Profit % Change
Sep2026 ₹163 Cr
32.38
Jun2026 ₹123 Cr
34.19
Mar2026 ₹92 Cr
430.66
Dec2025 ₹17 Cr
-83.73
Sep2025 ₹106 Cr
20.36
Jun2025 ₹88 Cr
-51.52
Mar2025 ₹183 Cr
28.63
Dec2024 ₹142 Cr -
Operating Margins
Q-o-Q

15.14 %

Y-o-Y

11.61 %

Quarters Operating Margin% % Change
Sep2026 31.63%
15.14
Jun2026 27.47%
27.95
Mar2026 21.47%
259.63
Dec2025 5.97%
-78.93
Sep2025 28.34%
4.81
Jun2025 27.04%
-36.90
Mar2025 42.85%
18.57
Dec2024 36.14% -

ONESOURCE SPECIALTY PHARMA Quarterly Profit After Tax

Profit After Tax(PAT)
Q-o-Q

129.96 %

Y-o-Y

448.25 %

Quarters Profit After Tax % Change
Sep2026 ₹57 Cr
129.96
Jun2026 ₹25 Cr
443.77
Mar2026 ₹5 Cr
Positive
Dec2025 ₹-89 Cr
Negative
Sep2025 ₹10 Cr
Positive
Jun2025 ₹0 Cr
Negative
Mar2025 ₹99 Cr
Positive
Dec2024 ₹-69 Cr -
PAT Margins
Q-o-Q

100.00 %

Y-o-Y

299.28 %

Quarters PAT Margin(%) % Change
Sep2026 11.14 %
100.00
Jun2026 5.57 %
420.56
Mar2026 1.07 %
Positive
Dec2025 -30.55 %
Negative
Sep2025 2.79 %
Positive
Jun2025 -0.06 %
Negative
Mar2025 23.29 %
Positive
Dec2024 -17.54 % -

ONESOURCE SPECIALTY PHARMA Quarterly Earnings Per Share (EPS)

EPS
Q-o-Q

129.82 %

Y-o-Y

444.57 %

Quarters EPS % Change
Sep2026 ₹5.01
129.82
Jun2026 ₹2.18
445.00
Mar2026 ₹0.4
Positive
Dec2025 ₹-7.74
Negative
Sep2025 ₹0.92
Positive
Jun2025 ₹-0.02
Negative
Mar2025 ₹8.61
Positive
Dec2024 ₹-6.02 -

You may also like the below Video Courses